190 related articles for article (PubMed ID: 6738408)
41. Strategies and controversies in the treatment of gout and hyperuricaemia.
Fam AG
Baillieres Clin Rheumatol; 1990 Aug; 4(2):177-92. PubMed ID: 2032295
[No Abstract] [Full Text] [Related]
42. Crystal arthropathies: recognizing and treating "the gouch".
Quillen DM
Prim Care; 2010 Dec; 37(4):703-11, v. PubMed ID: 21050952
[TBL] [Abstract][Full Text] [Related]
43. Gout and uric acid metabolism.
Arthritis Rheum; 1970; 13(5):553-69. PubMed ID: 4922854
[No Abstract] [Full Text] [Related]
44. [Gout--based on 110 cases. II].
Matusan J; Dubravcić M; Tukić A; Boschi S
Med Glas; 1968 Dec; 22(12):436-41. PubMed ID: 5199574
[No Abstract] [Full Text] [Related]
45. Lesinurad: A Review in Hyperuricaemia of Gout.
Deeks ED
Drugs Aging; 2017 May; 34(5):401-410. PubMed ID: 28425024
[TBL] [Abstract][Full Text] [Related]
46. [Hyperuricemia and gout--treatment].
Gröbner W; Walter-Sack I
Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
[No Abstract] [Full Text] [Related]
47. The current state of care in gout: Addressing the need for better understanding of an ancient disease.
Zychowicz ME; Pope RS; Graser E
J Am Acad Nurse Pract; 2010 Nov; 22 Suppl 1():623-36. PubMed ID: 21054636
[TBL] [Abstract][Full Text] [Related]
48. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi.
Emmerson BT
Australas Ann Med; 1967 Aug; 16(3):205-14. PubMed ID: 6056609
[No Abstract] [Full Text] [Related]
49. Tophaceous Gout in an Anorectic Patient Visualized by Dual Energy Computed Tomography (DECT).
Christensen HD; Sheta HM; Morillon MB; Hansen IM
Am J Case Rep; 2016 Jul; 17():494-8. PubMed ID: 27418121
[TBL] [Abstract][Full Text] [Related]
50. Management of gout.
Simkin PA
Ann Intern Med; 1979 May; 90(5):812-6. PubMed ID: 434690
[TBL] [Abstract][Full Text] [Related]
51. [The treatment of gout and the internal medical treatment of uric acid nephrolithiasis].
Zöllner N
Dtsch Med Wochenschr; 1968 Feb; 93(7):310-2. PubMed ID: 4296298
[No Abstract] [Full Text] [Related]
52. [Gout from the view of a special hospital for rheumatic patients].
Klotz H; Prohaska E; Salmhofer H; Schmid L
Wien Klin Wochenschr; 1971 Mar; 83(11):177-80. PubMed ID: 5314855
[No Abstract] [Full Text] [Related]
53. Editorial: Drugs used in hyperuricaemia.
S Afr Med J; 1974 Jun; 48(30):1278. PubMed ID: 4851506
[No Abstract] [Full Text] [Related]
54. [Gout: an overview of available urate lowering therapies].
Richette P
Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
[TBL] [Abstract][Full Text] [Related]
55. Influence of urate-lowering therapies on renal handling of uric acid.
Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
[TBL] [Abstract][Full Text] [Related]
56. [Hyperuricemia and gout; treatment of an acute attack of gout].
Gast LF; Cats A; van Romunde LK
Ned Tijdschr Geneeskd; 1983 Dec; 127(49):2235-7. PubMed ID: 6656915
[No Abstract] [Full Text] [Related]
57. Gout--what are the treatment options?
Schlesinger N; Dalbeth N; Perez-Ruiz F
Expert Opin Pharmacother; 2009 Jun; 10(8):1319-28. PubMed ID: 19463070
[TBL] [Abstract][Full Text] [Related]
58. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
Li-Yu J; Clayburne G; Sieck M; Beutler A; Rull M; Eisner E; Schumacher HR
J Rheumatol; 2001 Mar; 28(3):577-80. PubMed ID: 11296962
[TBL] [Abstract][Full Text] [Related]
59. [Drug therapy of hyperuricemia].
Gröbner W
Verh Dtsch Ges Inn Med; 1986; 92():492-7. PubMed ID: 3811551
[No Abstract] [Full Text] [Related]
60. Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout.
Graham GG; Stocker SL; Kannangara DRW; Day RO
Curr Rheumatol Rep; 2018 Jun; 20(8):47. PubMed ID: 29931553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
